Prokidney (PROK) Interest Expenses (2021 - 2026)

Prokidney's (PROK) quarterly Interest Expenses came in at $13.2 million in Q1 2026, down 0.69% year-on-year from $13.3 million in Q1 2025, and down 69.34% on a QoQ basis from $42.9 million in Q4 2025.

Prokidney (PROK) Interest Expenses (2021 - 2026) Analysis & Trends

Prokidney (PROK) has 6 years of Interest Expenses data on file, last reported at $13.2 million in Q1 2026.

  • On a quarterly basis, Interest Expenses fell 0.69% year-over-year to $13.2 million in Q1 2026; TTM through Mar 2026 was $80.9 million, a 173.25% increase from a year earlier, with the FY2025 full-year figure at $42.9 million, up 118.01% from the prior year.
  • Interest Expenses for Q1 2026 stood at $13.2 million, down from $42.9 million in the prior quarter.
  • Over the last five years, Interest Expenses for PROK reached as high as $3.6 billion in Q1 2023 and fell as low as $2000.0 in Q4 2024.
  • Historically, Interest Expenses has averaged $220.4 million across 5 years, with a median of $4.0 million in 2024.
  • On a YoY basis, Interest Expenses climbed as much as 25735614.29% in 2023 and fell as far as 99.99% in 2023.
  • Year by year, Interest Expenses stood at $24.8 million in 2022, then sank by 99.99% to $3000.0 in 2023, then plunged by 33.33% to $2000.0 in 2024, then jumped by 2146300.0% to $42.9 million in 2025, then slumped by 69.34% to $13.2 million in 2026.
  • Per Business Quant data, the three most recent Interest Expenses figures were $13.2 million in Q1 2026, $42.9 million in Q4 2025, and $1.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Oculis Holding AG 65,899.61 Bn 65,899.33 Bn - -42,141.15
2 Nanobiotix 1,933.82 Bn 1,933.76 Bn - -
3 Akari Therapeutics 1,022.34 Bn 1,022.34 Bn - 100,000.00
4 BeOne Medicines 472.68 Bn 467.89 Bn 1.35 Bn 32.89 Mn
5 Vertex Pharmaceuticals 122.24 Bn 114.99 Bn 2.59 Bn 420.30 Mn
6 Regeneron Pharmaceuticals 70.08 Bn 61.33 Bn 3.31 Bn 28.30 Mn
7 Belite Bio 62.46 Bn 62.46 Bn - -
8 Argenx Se 55.93 Bn 50.75 Bn 1.41 Bn -
9 Alnylam Pharmaceuticals 37.59 Bn 34.58 Bn 959.66 Mn 69.29 Mn
10 Prokidney 95.39 Mn 95.39 Mn - 13.16 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 13.16 Mn
Mar 31, 2026 13.16 Mn
Dec 31, 2025 42.93 Mn
Dec 31, 2025 42.93 Mn
Sep 30, 2025 1.58 Mn
Sep 30, 2025 1.58 Mn
Jun 30, 2025 11.60 Mn
Jun 30, 2025 11.60 Mn
Mar 31, 2025 13.25 Mn
Mar 31, 2025 13.25 Mn
Dec 31, 2024 2,000.00
Dec 31, 2024 2,000.00
Sep 30, 2024 2.20 Mn
Sep 30, 2024 2.20 Mn
Jun 30, 2024 12.33 Mn
Jun 30, 2024 12.33 Mn
Mar 31, 2024 4.04 Mn
Mar 31, 2024 4.04 Mn
Dec 31, 2023 3,000.00
Dec 31, 2023 3,000.00